Personalized treatment for social anxiety using iExposure
Testing the Role of Attentional and Audio Vocal Mechanisms in a New Internet- Based Intervention for Social Anxiety: iExposure
This study is testing if different personalized versions of an online treatment for social anxiety can help young people feel more comfortable in social situations.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 390 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Palo Alto University Academic / other |
| Locations | 1 site (Palo Alto, California) |
| Trial ID | NCT06409247 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on addressing social anxiety, which affects a significant portion of the youth population, particularly exacerbated by the COVID-19 pandemic. The study aims to optimize treatment responses by comparing standard iExposure with two enhanced versions that utilize different attention mechanisms: attention guidance and attention control. By personalizing the approach, the study seeks to improve access to effective treatments for individuals suffering from social anxiety. Participants will engage in simulated teleconferencing interactions to assess the effectiveness of these interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are fluent in English and exhibit clinically elevated symptoms of social anxiety.
Not a fit: Patients currently receiving cognitive behavioral therapy for social anxiety disorder or those with significant visual impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment outcomes for individuals with social anxiety, leading to better mental health and quality of life.
How similar studies have performed: While there is ongoing research into various interventions for social anxiety, this specific approach using personalized iExposure with attention mechanisms is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 or older * Fluent in English * Leibowitz Social Anxiety Scale \> 47 and endorses both social anxiety items on the Web Screening Questionnaire for Common Mental Disorders Exclusion Criteria: * Currently receiving CBT for Social Anxiety Disorder * Significant visual impairment precluding engagement in the simulated teleconferencing interactions * Unstable dose of psychotropic medications within 6 weeks prior to baseline assessment * Current alcohol or substance use disorder * Current or past bipolar disorder or psychosis
Where this trial is running
Palo Alto, California
- Palo Alto University — Palo Alto, California, United States (Recruiting)
Study contacts
- Study coordinator: Mikael Rubin, PhD
- Email: mrubin@paloaltou.edu
- Phone: 650-433-3805
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.